Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$142M |
| 2 |
Procter & Gamble
PG
|
+$74.5M |
| 3 |
PepsiCo
PEP
|
+$60.9M |
| 4 |
Pinduoduo
PDD
|
+$58.5M |
| 5 |
Johnson & Johnson
JNJ
|
+$56.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$565M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$337M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$335M |
| 4 |
Walmart Inc
WMT
|
+$314M |
| 5 |
Danaher
DHR
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 27.98% |
| 2 | Consumer Discretionary | 17.74% |
| 3 | Healthcare | 17.12% |
| 4 | Industrials | 3.53% |
| 5 | Financials | 3.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVRO
401
DELISTED
NEVRO CORP.
NVRO
| $3.01M | 0.02% |
37,092
+4,758
| +15% | +$477K |
|
402
Visteon
VC
$2.78B
| $2.99M | 0.02% |
26,927
-16,835
| -38% | -$1.87M |
|
403
Franklin Resources
BEN
$17.2B
| $2.99M | 0.02% |
89,245
-117,409
| -57% | -$3.86M |
|
404
Biogen
BIIB
$30.7B
| $2.98M | 0.02% |
12,404
-218
| -2% | -$56.1K |
|
|
NUVA
405
DELISTED
NuVasive, Inc.
NUVA
| $2.97M | 0.02% |
56,673
+8,243
| +17% | +$448K |
|
406
Haemonetics
HAE
$4B
| $2.97M | 0.02% |
55,975
+8,306
| +17% | +$506K |
|
407
Albertsons Companies
ACI
$5.83B
| $2.96M | 0.02% |
98,034
-354,554
| -78% | -$11.2M |
|
408
Acadia Healthcare
ACHC
$2.94B
| $2.95M | 0.02% |
48,540
+42,374
| +687% | +$2.53M |
|
409
CryoPort
CYRX
$762M
| $2.94M | 0.02% |
49,706
+6,591
| +15% | +$456K |
|
410
Workday
WDAY
$44.4B
| $2.94M | 0.02% |
10,757
-8,005
| -43% | -$2.22M |
|
411
Avery Dennison
AVY
$13.4B
| $2.93M | 0.02% |
13,547
+10,528
| +349% | +$2.25M |
|
412
Cal-Maine
CALM
$3.99B
| $2.93M | 0.02% |
79,199
-6,370
| -7% | -$231K |
|
413
Omnicom Group
OMC
$23.4B
| $2.89M | 0.02% |
39,504
+24,249
| +159% | +$1.72M |
|
414
Glaukos
GKOS
$10.6B
| $2.88M | 0.02% |
64,877
+20,753
| +47% | +$958K |
|
|
BIG
415
DELISTED
Big Lots, Inc.
BIG
| $2.84M | 0.02% |
63,021
+3,940
| +7% | +$179K |
|
416
Stride
LRN
$3.43B
| $2.81M | 0.02% |
84,407
+11,021
| +15% | +$380K |
|
417
Cheesecake Factory
CAKE
$5.33B
| $2.77M | 0.02% |
70,715
+25,968
| +58% | +$1.09M |
|
|
VNET
418
VNET Group
VNET
$2.09B
| $2.74M | 0.02% |
303,742
+66,488
| +28% | +$904K |
|
419
Strategic Education
STRA
$1.92B
| $2.74M | 0.02% |
47,390
+4,275
| +10% | +$268K |
|
420
Vertex Pharmaceuticals
VRTX
$126B
| $2.73M | 0.02% |
12,417
-2,700
| -18% | -$525K |
|
421
Pilgrim's Pride
PPC
$6.54B
| $2.71M | 0.02% |
95,991
-303,418
| -76% | -$8.63M |
|
422
Vornado Realty Trust
VNO
$7.38B
| $2.65M | 0.02% |
63,348
+41,709
| +193% | +$1.8M |
|
|
WBA
423
DELISTED
Walgreens Boots Alliance
WBA
| $2.6M | 0.02% |
49,835
-78,074
| -61% | -$3.78M |
|
424
Ares Management
ARES
$30.9B
| $2.58M | 0.02% |
31,728
+4,131
| +15% | +$336K |
|
|
BZUN
425
Baozun
BZUN
$172M
| $2.53M | 0.01% |
182,298
+38,728
| +27% | +$635K |
|
Similar funds
Ray Dalio's Q4 2021 Portfolio in Review
As of Q4 2021, Ray Dalio held 820 positions worth $17.2B, down 5.8% from $18.3B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Ray Dalio withdrew a net $1.89B in Q4 2021, closing 89 positions and reducing 292 holdings. Its most notable exit was Ecolab, an estimated $14.2M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Ray Dalio opened a new position in RTX Corp worth $16M.
- Ray Dalio's largest Q4 2021 buy was RTX Corp: 186,232 shares worth $16M.
- Ray Dalio added most to Alibaba in Q4 2021, an estimated $142M increase.
- Ray Dalio's biggest Q4 2021 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $565M.
- Ray Dalio fully exited Ecolab in Q4 2021, selling an estimated $14.2M.
- Ray Dalio's ten largest holdings make up 36% of its $17.2B portfolio in Q4 2021.
- Ray Dalio opened 137 new positions and closed 89 in Q4 2021.
- Ray Dalio's portfolio value fell 5.8% quarter-over-quarter to $17.2B.
Based on Bridgewater Associates's 13F filing for Q4 2021, filed 14 Feb 2022.